Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8790112 | Urologic Oncology: Seminars and Original Investigations | 2018 | 5 Pages |
Abstract
We confirmed reduced disease recurrence rates associated with 1 immediate postoperative intravesical instillation of mitomycin C in NMIBC patients. The benefit on recurrence-free survival of a postoperative intravesical instillation was preserved across all ages and therefore age by itself should not be taken into consideration when deciding to use it.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Evanguelos M.D., Ph.D., Matthew Ph.D., Yohann M.D., Malte M.D., Luis A. M.D., Bashir M.D., Idir M.D., Armin M.D., Evi M.D., Robert S. M.D., Yair M.D., Pierre I. M.D., Sten M.D., Shahrokh F. M.D., Ph.D.,